MiniMed 770G is the first AID system approved for use in children 2+; shipments in line with expected launch timing; MiniMed Mobile app also launched
Yesterday, Medtronic began shipping its MiniMed 770G system in the US, in line with launch expectations from earlier in the year. Medtronic Diabetes mascot “Lenny the Lion” (pictured below) broke the news via Twitter. As a reminder, MiniMed 770G received FDA approval in September, becoming the first AID system approved for use in children down to age 2.
MiniMed 770G consists of the MiniMed 700G series hardware (submitted for FDA review in 3Q19, includes Bluetooth connectivity) and the same algorithm as the MiniMed 670G system (SmartGuard Auto Mode). With Bluetooth connectivity, Medtronic has also launched the MiniMed Mobile (App Store; Google Play) smartphone app for secondary display, remote monitoring, and data uploading. The app nicely displays insulin on board and CGM readings on the main screen, with easy access to Time in Range metrics (see screenshots below). MiniMed 770G also includes a Guardian Sensor 3 CGM, Roche Accu-Chek Guide Link BGM (because Guardian Sensor 3 is an adjunctive CGM). While we are sure patients will appreciate these updates to the pump technology, the big win will come when patients are able to upgrade their 770G systems to the 780G algorithm for free when the new algorithm launches. Our last timeline update on 780G comes from May when we were told 780G would launch “later in the fiscal year” which ends April 2021.
As mentioned above, MiniMed 770G is approved for use in children 2+ years old, making it the first AID system available for 2-6-year-old patients in the US. We imagine many parents of young children with type 1 will be interested in using the 770G system, especially with the potential to update to 780G in the future. For those interesting in learning about MiniMed 770G for children, Medtronic created an entire 770G webpage dedicated to children. The page highlights the system’s Bluetooth and smartphone connectivity that allows kids to discretely check their glucose from an app and also gives care providers access to the child’s data.
--by Hanna Gutow, Albert Cai, and Kelly Close